Plain-English translation of NCT06618612 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether PuraPly AM or PuraPly XT—special wound matrices designed to help stubborn diabetic foot ulcers heal—work better when added to your regular wound care compared to regular care alone. The treatment is applied directly to your wound to help it close. Researchers will compare healing outcomes over 12 weeks.
Many diabetic foot ulcers don't heal well with standard care alone, and patients face serious complications like infection or amputation. This trial is testing whether adding this specialized wound matrix treatment can help more ulcers heal completely.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either standard wound care alone or standard care plus one of the new wound matrix treatments. You'll visit the study clinic weekly for up to 12 weeks so doctors can check how your ulcer is healing. If your wound closes completely, you'll have one more visit two weeks later to confirm it stays healed. The treatment involves applying the wound matrix directly to your ulcer as part of your regular wound care routine.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States